pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Small Molecule · news · pharmadog
← back to Small Molecule
News · Small Molecule
468
stories
Apr 30, 26
Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch
biopharma dive
Apr 29, 26
Chiesi to buy KalVista in $1.9B deal for rare disease drug
biopharma dive
Apr 29, 26
STAT+: A patent win for Pfizer and BridgeBio
stat
Apr 29, 26
STAT+: Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
stat
Apr 29, 26
Food safety experts warn of USDA brain drain
stat
Apr 28, 26
STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic access
stat
Apr 28, 26
Incyte claims double Phase 3 win in vitiligo, will file for approval
endpoints
Apr 28, 26
Coultreon banks $125M to support testing of former Galapagos immune drug
biopharma dive
Apr 27, 26
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
stat
Apr 27, 26
Veradermics soars on positive data for baldness treatment
biopharma dive
Apr 27, 26
Veradermics wins at growing hair with oral Rogaine in first key test as a public company
endpoints
Apr 27, 26
STAT+: Veradermics’ hair loss drug succeeds in late-stage trial
stat
Apr 24, 26
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
biopharma dive
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
Apr 23, 26
Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloud
endpoints
Apr 23, 26
Roche says its investigational breast cancer pill could outsell Herceptin
endpoints
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: KymaThera corrals $80M; RougeTx lifts off with $58M
fiercebiotech
← prev
page 16 of 16
next →
